Subtype
Intracranial Neoplasm
CI-CAN-00001030Explore in graph →
Non-malignant522 active trials34 evidence items
- NCIt
- C4953
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001030Explore in graph →
Clinical trials
2,178 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04528316 | Physical Activity on Postural Stability and Coordination in Children With Posterior Fossa Tumor | completed | N/A | 60 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT01619865 | Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors(GA-68) | completed | Phase 1 / Phase 2 | 223 | Sue O'DorisioOTHER | 1 | Jul 27, 2021 | clinicaltrials |
| NCT01217437 | Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors | completed | Phase 2 | 108 | National Cancer Institute (NCI)NIH | 5 | Jul 23, 2021 | clinicaltrials |
| NCT00879437 | Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma | completed | Phase 2 | 38 | Baylor College of MedicineOTHER | 1 | Jul 21, 2021 | clinicaltrials |
| NCT01051557 | Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma | completed | Phase 1 / Phase 2 | 36 | National Cancer Institute (NCI)NIH | 1 | Jul 19, 2021 | clinicaltrials |
| NCT02798406 | Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects(CAPTIVE) | completed | Phase 2 | 49 | DNAtrix, Inc.INDUSTRY | 2 | Jul 15, 2021 | clinicaltrials |
| NCT00528437 | Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors | completed | Phase 2 | 46 | NYU Langone HealthOTHER | 2 | Jul 8, 2021 | clinicaltrials |
| NCT01520870 | Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT. | completed | Phase 2 | 49 | Grupo Español de Investigación en NeurooncologíaOTHER | 1 | Jul 6, 2021 | clinicaltrials |
| NCT04944875 | Effects of Music and Maternal Voice on Sedation Depth and Sedative Use During Pediatric Magnetic Resonance Imaging. | completed | N/A | 210 | TC Erciyes UniversityOTHER | 1 | Jun 30, 2021 | clinicaltrials |
| NCT02947373 | Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain Tumors | completed | Phase 1 | 10 | University of California, San FranciscoOTHER | 1 | Jun 24, 2021 | clinicaltrials |
| NCT04937335 | Craniopharyngioma With Tumoral Hemorrhage | completed | — | 185 | Tongji HospitalOTHER | 0 | Jun 24, 2021 | clinicaltrials |
| NCT01800032 | PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1) | completed | — | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT04840771 | Predictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery | completed | — | 8 | Federico II UniversityOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT03930173 | 18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation Necrosis | completed | Early Phase 1 | 18 | Case Comprehensive Cancer CenterOTHER | 1 | May 5, 2021 | clinicaltrials |
| NCT04832672 | Sequence of Radiation and Targeted Therapy in Brain Metastases | completed | — | 570 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT02085070 | MK-3475 in Melanoma and NSCLC Patients With Brain Metastases | completed | Phase 2 | 65 | Yale UniversityOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT03222258 | Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients | completed | — | 444 | Seoul National University HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04607525 | Dexmedetomidine Infusion Effect on Hemodynamic Variables During Craniotomy | completed | Phase 4 | 40 | Ain Shams UniversityOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT02147028 | Hippocampal Sparing Whole Brain Radiotherapy vs Conventional Whole Brain Radiotherapy in Patients With Brain Metastases(HIPPO) | completed | Phase 2 | 23 | University College, LondonOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT01730274 | Cerebellum - Cognitive Outcome and Functional Connectivity | completed | — | 31 | Medical University of ViennaOTHER | 1 | Feb 24, 2021 | clinicaltrials |
| NCT04546386 | Long-term Follow up for Retinal Vascular Changes After Endoscopic Endonasal Pituitary Surgery. | completed | — | 14 | Federico II UniversityOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT01689402 | MRI for the Early Evaluation of Acute Intracerebral Hemorrhage | completed | — | 60 | Bispebjerg HospitalOTHER | 1 | Jan 28, 2021 | clinicaltrials |
| NCT03615404 | Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma(ATTAC-P) | completed | Phase 1 | 11 | Gary Archer Ph.D.OTHER | 1 | Jan 28, 2021 | clinicaltrials |
| NCT01414738 | Hippocampal-Avoiding Whole Brain Irradiation With Simultaneous Integrated Boost for Treatment of Brain Metastases | completed | Phase 2 | 50 | University of Texas Southwestern Medical CenterOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT01125046 | Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas | completed | Phase 2 | 50 | Northwestern UniversityOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT02441062 | Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors | completed | Phase 2 | 122 | Sue O'DorisioOTHER | 1 | Dec 21, 2020 | clinicaltrials |
| NCT00880308 | Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors | completed | Phase 1 | 103 | Novartis PharmaceuticalsINDUSTRY | 4 | Dec 19, 2020 | clinicaltrials |
| NCT01208831 | An East Asian Study of LDE225 | completed | Phase 1 | 45 | Novartis PharmaceuticalsINDUSTRY | 3 | Dec 19, 2020 | clinicaltrials |
| NCT00597246 | Imaging Brain Tumors With FACBC and Methionine | completed | N/A | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT00979810 | Image-Guided Stereotactic Biopsy of High Grade Gliomas | completed | N/A | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT02605746 | Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis | completed | Early Phase 1 | 10 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Dec 11, 2020 | clinicaltrials |
| NCT01024907 | Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas | completed | Phase 1 / Phase 2 | 23 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT03026699 | Refining and Testing the Electronic Social Network Assessment Program (eSNAP) | completed | — | 62 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT03090386 | Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients | completed | — | 30 | Mayo ClinicOTHER | 1 | Dec 1, 2020 | clinicaltrials |
| NCT00001981 | The Treatment and Natural History of Acromegaly | completed | — | 117 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Nov 27, 2020 | clinicaltrials |
| NCT03444519 | The Therapeutic Time Window of Mannitol During Craniotomy for Optimal Brain Relaxation in Patients With Supratentorial Tumours | completed | N/A | 100 | Huashan HospitalOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT04634188 | Role and Value of Inflammatory Markers in Brain Tumors : A Case Controlled Study | completed | — | 35 | Universitas Sumatera UtaraOTHER | 1 | Nov 18, 2020 | clinicaltrials |
| NCT00395863 | Multihance at 3 Tesla (3T) in Brain Tumors | completed | Phase 4 | 46 | Bracco Diagnostics, IncINDUSTRY | 1 | Nov 5, 2020 | clinicaltrials |
| NCT01635283 | Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma | completed | Phase 2 | 5 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT00033254 | Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases | completed | Phase 3 | 332 | National Cancer Institute (NCI)NIH | 1 | Oct 30, 2020 | clinicaltrials |
| NCT00590954 | Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas | completed | Phase 2 | 32 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT02878707 | The Neuroprotective Effects of Dexmedetomidine During Brain Surgery | completed | N/A | 160 | National Taiwan University HospitalOTHER | 1 | Sep 22, 2020 | clinicaltrials |
| NCT00001686 | Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases | completed | — | 482 | National Cancer Institute (NCI)NIH | 1 | Sep 10, 2020 | clinicaltrials |
| NCT01674582 | Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters | completed | N/A | 150 | Lund University HospitalOTHER | 1 | Sep 3, 2020 | clinicaltrials |
| NCT02271711 | Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors | completed | Phase 1 | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 2, 2020 | clinicaltrials |
| NCT00883688 | Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 26, 2020 | clinicaltrials |
| NCT04525053 | Dosimetric Validation of Scans Generated by GAN From Pre-therapeutic MRI in Stereotactic Cerebral Radiotherapy(SBRT-IRM) | completed | — | 184 | University Hospital, BrestOTHER | 1 | Aug 25, 2020 | clinicaltrials |
| NCT01228448 | In-Room PET in Proton Radiation Therapy | completed | N/A | 59 | Massachusetts General HospitalOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT00179803 | Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors | completed | Phase 2 | 24 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Aug 5, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Aug 4, 2021source: clinicaltrials